Intas Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 175.47 Cr
as on 02-07-2024
- Paid Up Capital ₹ 114.77 Cr
as on 02-07-2024
- Company Age 39 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 754.50 Cr
as on 02-07-2024
- Satisfied Charges ₹ 7,174.94 Cr
as on 02-07-2024
- Revenue -3.44%
(FY 2023)
- Profit -17.74%
(FY 2023)
- Ebitda -18.86%
(FY 2023)
- Net Worth 13.06%
(FY 2023)
- Total Assets 8.17%
(FY 2023)
About Intas Pharmaceuticals
The Corporate was formerly known as Intas Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 175.47 Cr and a paid-up capital of Rs 114.77 Cr.
The company currently has active open charges totaling ₹754.50 Cr. The company has closed loans amounting to ₹7,174.94 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Intas Pharmaceuticals Limited India are Jayesh Shah as CFO and Manoj Nair as Company Secretary. Urmish Chudgar, Binish Chudgar, Hasmukh Chudgar, and Eight other members serve as directors at the Company.
- CIN/LLPIN
U24231GJ1985PLC007866
- Company No.
007866
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
31 May 1985
- Date of AGM
31 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Intas Pharmaceuticals Limited offer?
Intas Pharmaceuticals Limited offers a wide range of products and services, including Hair Care, Hair Growth for Men, Specialty Supplements, Probiotics, Skin Care, Facewash, Vitamins & Supplements, Vitamins A-Z, Health Conditions, Kidney Care.
Who are the key members and board of directors at Intas Pharmaceuticals?
Executive Team (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Urmish Chudgar  | Managing Director | 30-Sep-1996 | Current |
| Binish Chudgar | Managing Director | 31-May-1985 | Current |
| Nimish Chudgar | Managing Director | 31-May-1985 | Current |
| Jayesh Shah | CFO | 21-Mar-2023 | Current |
| Manoj Nair | Company Secretary | 08-Jun-2007 | Current |
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
John Goddard  | Director | 09-Feb-2011 | Current |
| Hasmukh Chudgar | Whole-Time Director | 31-May-1985 | Current |
| Sanjay Kukreja | Director | 21-May-2020 | Current |
| Surender Kumar | Director | 09-Feb-2011 | Current |
| Tilokchand Ostwal | Director | 19-Mar-2011 | Current |
| Jayesh Shah | Whole-Time Director and Cfo | 21-Mar-2018 | Current |
Financial Performance and Corporate Structure Insights of Intas Pharmaceuticals.
Intas Pharmaceuticals Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.44% decrease. The company also saw a substantial fall in profitability, with a 17.74% decrease in profit. The company's net worth Soared by an impressive increase of 13.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Intas Pharmaceuticals?
In 2023, Intas Pharmaceuticals had a promoter holding of 83.84% and a public holding of 16.16%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tfs Business Advisors India Private LimitedActive 18 years 10 monthsSurender Kumar is a mutual person
One Advertising And Communication Services LimitedActive 23 years 4 monthsJayesh Shah is a mutual person
Gebbs Healthcare Solutions Private LimitedActive 20 years 11 monthsSanjay Kukreja is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Jun 1999 | ₹750.00 Cr | Open |
Dena Bank Creation Date: 01 May 1998 | ₹4.50 Cr | Open |
Standard Chartered Bank Creation Date: 04 Sep 2017 | ₹184.62 Cr | Satisfied |
How Many Employees Work at Intas Pharmaceuticals?
Intas Pharmaceuticals has a workforce of 18317 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Intas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intas Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
